| Joan F Gaela, MD | |
|
4320 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5925 | |
| (907) 729-3971 | |
| (907) 729-1542 |
| Full Name | Joan F Gaela |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750470142 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5320 (Alaska) | Primary |
| Entity Name | Arctic Slope Native Association Ltd |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306933643 PECOS PAC ID: 4082524665 Enrollment ID: O20080129000864 |
News Archive
In this post in the Guardian's "Poverty Matters" blog, Carel IJsselmuiden, executive director of the Council on Health for Development Group, writes that "Africa must turn its health research into treatments for African people," noting, "Despite large investments being made by donors in health products and delivery of health services, a large percentage of Africans still have limited access to sufficient and quality healthcare - especially in rural areas."
AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.
› Verified 8 days ago
| Entity Name | Arctic Slope Native Association Ltd |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306933643 PECOS PAC ID: 4082524665 Enrollment ID: O20161220001889 |
News Archive
In this post in the Guardian's "Poverty Matters" blog, Carel IJsselmuiden, executive director of the Council on Health for Development Group, writes that "Africa must turn its health research into treatments for African people," noting, "Despite large investments being made by donors in health products and delivery of health services, a large percentage of Africans still have limited access to sufficient and quality healthcare - especially in rural areas."
AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joan F Gaela, MD 4320 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5925 Ph: (907) 729-3971 | Joan F Gaela, MD 4320 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5925 Ph: (907) 729-3971 |
News Archive
In this post in the Guardian's "Poverty Matters" blog, Carel IJsselmuiden, executive director of the Council on Health for Development Group, writes that "Africa must turn its health research into treatments for African people," noting, "Despite large investments being made by donors in health products and delivery of health services, a large percentage of Africans still have limited access to sufficient and quality healthcare - especially in rural areas."
AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.
› Verified 8 days ago
Candace L Clawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1624 Fax: 907-729-1634 | |
Dr. William Murray Buttner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-561-4806 | |
Robert L Mcalister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-2992 | |
Shane W Cummings, M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515 Phone: 907-344-2400 Fax: 907-344-2404 | |
Jeremy D Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Compassion Cir, Anchorage, AK 99504 Phone: 907-212-9200 Fax: 907-212-9283 | |
Kelton Hillard Oliver, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12302 Woodward Dr, Anchorage, AK 99516 Phone: 907-580-0002 | |
Ryan T. Mcwilliams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508 Phone: 907-729-6321 |